These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 7590898)
21. CD4+ lymphocytes in perinatal human immunodeficiency virus (HIV) infection: evidence for pregnancy-induced immune depression in uninfected and HIV-infected women. Rich KC; Siegel JN; Jennings C; Rydman RJ; Landay AL J Infect Dis; 1995 Nov; 172(5):1221-7. PubMed ID: 7594657 [TBL] [Abstract][Full Text] [Related]
22. The prognostic significance in HIV infection of immune activation represented by cell surface antigen and plasma activation marker changes. Plaeger S; Bass HZ; Nishanian P; Thomas J; Aziz N; Detels R; King J; Cumberland W; Kemeny M; Fahey JL Clin Immunol; 1999 Feb; 90(2):238-46. PubMed ID: 10080836 [TBL] [Abstract][Full Text] [Related]
23. Immunophenotypic analysis of HIV-infected children: alterations within the first year of life, changes with disease progression, and longitudinal analyses of lymphocyte subsets. McCloskey TW; Kohn N; Lesser M; Bakshi S; Pahwa S Cytometry; 2001 Jun; 46(3):157-65. PubMed ID: 11449406 [TBL] [Abstract][Full Text] [Related]
24. Increased HLA-DR expression on peripheral blood monocytes in subsets of subjects with primary HIV infection is associated with elevated CD4 T-cell apoptosis and CD4 T-cell depletion. Gascon RL; Narváez AB; Zhang R; Kahn JO; Hecht FM; Herndier BG; McGrath MS J Acquir Immune Defic Syndr; 2002 Jun; 30(2):146-53. PubMed ID: 12045676 [TBL] [Abstract][Full Text] [Related]
25. Shigella infection induces cellular activation of T and B cells and distinct species-related changes in peripheral blood lymphocyte subsets during the course of the disease. Islam D; Bardhan PK; Lindberg AA; Christensson B Infect Immun; 1995 Aug; 63(8):2941-9. PubMed ID: 7622216 [TBL] [Abstract][Full Text] [Related]
26. Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study. Giorgi JV; Liu Z; Hultin LE; Cumberland WG; Hennessey K; Detels R J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):904-12. PubMed ID: 7686224 [TBL] [Abstract][Full Text] [Related]
27. CD8+,CD38+ lymphocyte percent: a useful immunological marker for monitoring HIV-1-infected patients. Mocroft A; Bofill M; Lipman M; Medina E; Borthwick N; Timms A; Batista L; Winter M; Sabin CA; Johnson M; Lee CA; Phillips A; Janossy G J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Feb; 14(2):158-62. PubMed ID: 9052725 [TBL] [Abstract][Full Text] [Related]
28. [T-lymphocyte immune in HIV-infected people and AIDS patients in China]. Li T; Qiu Z; Wang A; Sheng R Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1391-5. PubMed ID: 12509921 [TBL] [Abstract][Full Text] [Related]
29. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy. d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625 [TBL] [Abstract][Full Text] [Related]
30. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. Kelleher AD; Carr A; Zaunders J; Cooper DA J Infect Dis; 1996 Feb; 173(2):321-9. PubMed ID: 8568292 [TBL] [Abstract][Full Text] [Related]
32. Different meaning of CD38 molecule expression on CD4+ and CD8+ cells of children perinatally infected with human immunodeficiency virus type 1 infection surviving longer than five years. de Martino M; Rossi ME; Azzari C; Gelli MG; Galli L; Vierucci A Pediatr Res; 1998 Jun; 43(6):752-8. PubMed ID: 9621984 [TBL] [Abstract][Full Text] [Related]
33. HLA-DR expression on regulatory T cells is closely associated with the global immune activation in HIV-1 infected subjects naïve to antiretroviral therapy. Xiao J; Qian KL; Cao QH; Qiu CL; Qiu C; Xue YL; Zhang XY; Zhong P; Xu JQ; Li MY; Wang Y Chin Med J (Engl); 2011 Aug; 124(15):2340-6. PubMed ID: 21933566 [TBL] [Abstract][Full Text] [Related]
34. A high proportion of the V delta 1+ synovial fluid gamma delta T cells in juvenile rheumatoid arthritis patients express the very early activation marker CD69, but carry the high molecular weight isoform of the leucocyte common antigen (CD45RA). Kjeldsen-Kragh J; Quayle AJ; Vinje O; Natvig JB; Førre O Clin Exp Immunol; 1993 Feb; 91(2):202-6. PubMed ID: 8428387 [TBL] [Abstract][Full Text] [Related]
35. Differential susceptibility of resting CD4(+) T lymphocytes to a T-tropic and a macrophage (M)-tropic human immunodeficiency virus type 1 is associated with their surface expression of CD38 molecules. Horikoshi H; Kinomoto M; Sasao F; Mukai T; Luftig RB; Ikuta K Virus Res; 2001 Jan; 73(1):1-16. PubMed ID: 11163640 [TBL] [Abstract][Full Text] [Related]
36. Expression of regeneration and tolerance factor correlates directly with human immunodeficiency virus infection and inversely with hepatitis C virus infection. Sung CC; Boomer JS; Givens TS; DuChateau BK; Lepe MR; Feller A; Westerman MP; Gilman-Sachs A; Chedid A; Beaman KD Clin Diagn Lab Immunol; 2000 Mar; 7(2):200-5. PubMed ID: 10702493 [TBL] [Abstract][Full Text] [Related]
37. CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+ CD38- CD8+ cells is associated with subsequent stable CD4+ cell levels. The Multicenter AIDS Cohort Study Group. Giorgi JV; Ho HN; Hirji K; Chou CC; Hultin LE; O'Rourke S; Park L; Margolick JB; Ferbas J; Phair JP J Infect Dis; 1994 Oct; 170(4):775-81. PubMed ID: 7930717 [TBL] [Abstract][Full Text] [Related]
38. Subcutaneous interleukin-2 in combination with anti-retroviral therapy for treatment of HIV-1-infected subjects. Larsen CS; Ostergård L; Møller BK; Buhl MR Scand J Infect Dis; 2000; 32(2):153-60. PubMed ID: 10826900 [TBL] [Abstract][Full Text] [Related]
39. Changes in viral expression and cytokine profile induced by a polyantigenic immunomodulator in HIV-infected peripheral blood mononuclear cells. Ríos Z; Ríos EO; Garcia MI; De Leon C; Guzman LM; Rodriguez W; Romero D; Hunter R Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S93-101. PubMed ID: 8574153 [TBL] [Abstract][Full Text] [Related]
40. T cell activation and disease severity in HIV infection. Mahalingam M; Peakman M; Davies ET; Pozniak A; McManus TJ; Vergani D Clin Exp Immunol; 1993 Sep; 93(3):337-43. PubMed ID: 8103715 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]